These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34185525)

  • 41. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent innovative advances in the discovery of selective HDAC6 inhibitors.
    T Tavares M; Shen S
    Future Med Chem; 2021 Jun; 13(12):1017-1019. PubMed ID: 33906379
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.
    Huang WJ; Chen CC; Chao SW; Yu CC; Yang CY; Guh JH; Lin YC; Kuo CI; Yang P; Chang CI
    Eur J Med Chem; 2011 Sep; 46(9):4042-9. PubMed ID: 21712146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of 3-subsitution of quinolinehydroxamic acids on selectivity of histone deacetylase isoforms.
    Mehndiratta S; Chen MC; Chao YH; Lee CH; Liou JP; Lai MJ; Lee HY
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):74-84. PubMed ID: 33161799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Syntheses and Biological Evaluation of Novel Hydroxamic Acid Derivatives Containing Purine Moiety as Histone Deacetylase Inhibitors.
    Xu Z; Yang Y; Mai X; Liu B; Xiong Y; Feng L; Liao Y; Zhang Y; Wang H; Ouyang L; Liu S
    Chem Pharm Bull (Tokyo); 2018; 66(4):439-451. PubMed ID: 29607910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of novel quinazoline derivatives as potent antiplasmodial agents.
    Bouchut A; Rotili D; Pierrot C; Valente S; Lafitte S; Schultz J; Hoglund U; Mazzone R; Lucidi A; Fabrizi G; Pechalrieu D; Arimondo PB; Skinner-Adams TS; Chua MJ; Andrews KT; Mai A; Khalife J
    Eur J Med Chem; 2019 Jan; 161():277-291. PubMed ID: 30366254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors.
    Shahidul Islam M; Nurul Islam M; Ashraful Hoque M; Nishino N; Kato T; Kim HJ; Ito A; Yoshida M
    Bioorg Chem; 2015 Apr; 59():145-50. PubMed ID: 25797804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thousands of chemical starting points for antimalarial lead identification.
    Gamo FJ; Sanz LM; Vidal J; de Cozar C; Alvarez E; Lavandera JL; Vanderwall DE; Green DV; Kumar V; Hasan S; Brown JR; Peishoff CE; Cardon LR; Garcia-Bustos JF
    Nature; 2010 May; 465(7296):305-10. PubMed ID: 20485427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
    Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
    Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT; Anh DT; Hai PT; Huong LT; Park EJ; Choi JE; Kang JS; Dung PTP; Han SB; Nam NH
    Chem Biodivers; 2018 Jun; 15(6):e1800027. PubMed ID: 29667768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and antimalarial activity of new atovaquone derivatives.
    El Hage S; Ane M; Stigliani JL; Marjorie M; Vial H; Baziard-Mouysset G; Payard M
    Eur J Med Chem; 2009 Nov; 44(11):4778-82. PubMed ID: 19747753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
    Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New benzothiazole/thiazole-containing hydroxamic acids as potent histone deacetylase inhibitors and antitumor agents.
    Tung TT; Oanh DT; Dung PT; Hue VT; Park SH; Han BW; Kim Y; Hong JT; Han SB; Nam NH
    Med Chem; 2013 Dec; 9(8):1051-7. PubMed ID: 23521008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
    Lucumi E; Darling C; Jo H; Napper AD; Chandramohanadas R; Fisher N; Shone AE; Jing H; Ward SA; Biagini GA; DeGrado WF; Diamond SL; Greenbaum DC
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3597-604. PubMed ID: 20547797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
    Vögerl K; Ong N; Senger J; Herp D; Schmidtkunz K; Marek M; Müller M; Bartel K; Shaik TB; Porter NJ; Robaa D; Christianson DW; Romier C; Sippl W; Jung M; Bracher F
    J Med Chem; 2019 Feb; 62(3):1138-1166. PubMed ID: 30645113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.
    Andrews KT; Walduck A; Kelso MJ; Fairlie DP; Saul A; Parsons PG
    Int J Parasitol; 2000 May; 30(6):761-8. PubMed ID: 10856511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
    Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite Strains.
    Le Manach C; Paquet T; Wicht K; Nchinda AT; Brunschwig C; Njoroge M; Gibhard L; Taylor D; Lawrence N; Wittlin S; Eyermann CJ; Basarab GS; Duffy J; Fish PV; Street LJ; Chibale K
    J Med Chem; 2018 Oct; 61(20):9371-9385. PubMed ID: 30256636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.